Correlation Between Skechers USA and Rapport Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Skechers USA and Rapport Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Skechers USA and Rapport Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Skechers USA and Rapport Therapeutics, Common, you can compare the effects of market volatilities on Skechers USA and Rapport Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Skechers USA with a short position of Rapport Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Skechers USA and Rapport Therapeutics,.
Diversification Opportunities for Skechers USA and Rapport Therapeutics,
-0.8 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Skechers and Rapport is -0.8. Overlapping area represents the amount of risk that can be diversified away by holding Skechers USA and Rapport Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rapport Therapeutics, and Skechers USA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Skechers USA are associated (or correlated) with Rapport Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rapport Therapeutics, has no effect on the direction of Skechers USA i.e., Skechers USA and Rapport Therapeutics, go up and down completely randomly.
Pair Corralation between Skechers USA and Rapport Therapeutics,
Considering the 90-day investment horizon Skechers USA is expected to generate 0.35 times more return on investment than Rapport Therapeutics,. However, Skechers USA is 2.88 times less risky than Rapport Therapeutics,. It trades about 0.29 of its potential returns per unit of risk. Rapport Therapeutics, Common is currently generating about -0.07 per unit of risk. If you would invest 6,729 in Skechers USA on November 3, 2024 and sell it today you would earn a total of 805.00 from holding Skechers USA or generate 11.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Skechers USA vs. Rapport Therapeutics, Common
Performance |
| Timeline |
| Skechers USA |
| Rapport Therapeutics, |
Skechers USA and Rapport Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Skechers USA and Rapport Therapeutics,
The main advantage of trading using opposite Skechers USA and Rapport Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Skechers USA position performs unexpectedly, Rapport Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rapport Therapeutics, will offset losses from the drop in Rapport Therapeutics,'s long position.| Skechers USA vs. Crocs Inc | Skechers USA vs. On Holding | Skechers USA vs. Nike Inc | Skechers USA vs. Designer Brands |
| Rapport Therapeutics, vs. CDW Corp | Rapport Therapeutics, vs. Bm Technologies | Rapport Therapeutics, vs. Datadog | Rapport Therapeutics, vs. Albertsons Companies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| CEOs Directory Screen CEOs from public companies around the world |